SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-000174
Filing Date
2023-01-13
Accepted
2023-01-13 08:40:42
Documents
47
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cnbx_i10q-113022.htm   iXBRL 10-Q 409605
2 CERTIFICATION cnbx_ex3101.htm EX-31.1 10446
3 CERTIFICATION cnbx_ex3102.htm EX-31.2 10215
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 4860
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4790
6 GRAPHIC image_001.jpg GRAPHIC 14829
7 GRAPHIC image_002.jpg GRAPHIC 16415
8 GRAPHIC image_003.jpg GRAPHIC 13583
9 GRAPHIC image_004.jpg GRAPHIC 7692
10 GRAPHIC image_005.jpg GRAPHIC 33823
11 GRAPHIC image_006.jpg GRAPHIC 20921
12 GRAPHIC image_007.jpg GRAPHIC 22999
13 GRAPHIC image_008.jpg GRAPHIC 27652
14 GRAPHIC image_009.jpg GRAPHIC 3734
15 GRAPHIC image_010.jpg GRAPHIC 26436
16 GRAPHIC image_011.jpg GRAPHIC 6065
17 GRAPHIC image_014.jpg GRAPHIC 1481
18 GRAPHIC image_015.jpg GRAPHIC 17138
  Complete submission text file 0001683168-23-000174.txt   2069335

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE cnbx-20221130.xsd EX-101.SCH 11369
20 XBRL CALCULATION FILE cnbx-20221130_cal.xml EX-101.CAL 21244
21 XBRL DEFINITION FILE cnbx-20221130_def.xml EX-101.DEF 20848
22 XBRL LABEL FILE cnbx-20221130_lab.xml EX-101.LAB 106818
23 XBRL PRESENTATION FILE cnbx-20221130_pre.xml EX-101.PRE 80107
41 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10q-113022_htm.xml XML 81866
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 23527348
SIC: 2834 Pharmaceutical Preparations